Pegasus Biotech Incorporated is an active federal corporation (corporation number 11741039). Its business number is 760829879. It was incorporated on Nov 15, 2019 under the Canada Business Corporations Act and its registered office is in Hartsville, Prince Edward Island. Its annual return for 2026 is due by Jan 14, 2027. It has three directors on record.
Corporate details
- Corporation number
- 11741039
- Business number
- 760829879
- Status
- Active
- Governing law
- Canada Business Corporations Act
- Incorporated
- Nov 15, 2019
- Corporation type
- Non-distributing corporation with 50 or fewer shareholdersAs declared in its 2025 annual return.
- Registered office
- 3282 Hopedale Rd
Hartsville PE C0A 1Y0 - Number of directors
- At least 1, at most 10As the articles allow.
Annual filings
- Anniversary date
- Nov 15The date of incorporation, amalgamation or continuance.
- Annual filing period
- Nov 15 to Jan 14 each year
- Last annual meeting
- Oct 27, 2025
| Year | Annual return | Annual meeting |
|---|---|---|
| 2026 | Due now Due by Jan 14, 2027 | |
| 2025 | Filed | Oct 27, 2025 |
| 2024 | Filed | Nov 4, 2024 |
The last annual return filed, and each year since.
Directors
Loading the directors from the federal record...
Federal grants and contributions
10 agreements since 2021, worth $1,978,323 in all.
| Department | Program | Value | Starts |
|---|---|---|---|
| National Research Council Canada | CIIP Singapore - PEGASUS-BPE-CAR-T: Cost-Effective CAR-TCR Development with Pegasus Bio's BPE Plasmid Platform | $600,000 | May 1, 2026 |
| National Research Council Canada | Participation in the Canadian Co-Innovation Mission To The Eureka GIS and Swiss Biotech Day in Switzerland – May 2026 | $3,975 | Mar 11, 2026 |
| National Research Council Canada | UK Biomanufacturing - 10141267 - BPE Human Vaccines - Implementation of High Yielding Plasmid DNA Platform for Human Vaccine Manufacturing | $514,123 | Apr 1, 2025 |
| Atlantic Canada Opportunities Agency | 226832 | $50,000 | Nov 13, 2024 |
| National Research Council Canada | BPE Plasmid Scale Up | $349,715 | Apr 1, 2024 |
| National Research Council Canada | ICAP – International Co-Innovation Action Plan | $50,000 | Feb 1, 2024 |
| National Research Council Canada | BPE Technology Development | $298,514 | Jan 2, 2023 |
| National Research Council Canada | IP Assist: Intellectual Property Strategy Engagement | $12,004 | Nov 14, 2022 |
| National Research Council Canada | DNA Vaccine Platform Development | $49,992 | Apr 1, 2022 |
| Atlantic Canada Opportunities Agency | 220310 | $50,000 | Dec 22, 2021 |
As each federal department publishes them (proactive disclosure). A value is the agreement's total as last amended; the money may be paid over several years. Search every federal grant.
Names
| Name | Form | In use since |
|---|---|---|
| Pegasus Biotech Incorporated | Name | Nov 15, 2019 |
Filings and certificates
| What | Date |
|---|---|
| Articles amended | Feb 8, 2023 |
| Incorporated | Nov 15, 2019 |
Registered in a province as well? Find provincial registrations(opens in a new tab). Something wrong or out of date? Request a correction.